The results regarding AN content in the supernatant highlighted the potential of ARI to induce AN secretion, an adipokine having beneficial effects, by counteracting insulin resistance and hepatic steatosis through the activation of glucose utilization in different tissues via adenosine monophosphate (AMP)-activated protein kinase and PPAR-α activation [18]. This evidence concerns the gene PPARA and fatty liver disease.